# Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children

> **NCT05354258** · NA · UNKNOWN · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 600 (estimated)

## Conditions studied

- Malaria
- Soil Transmitted Helminths
- Schistosomiasis
- Integrated Control
- Seasonal Malaria Chemoprevention
- Mass Drug Administration With Anthelminthic Drugs

## Interventions

- **DRUG:** Albendazole
- **DRUG:** Praziquantel
- **DRUG:** Amodiaquine
- **DRUG:** Sulfadoxine pyrimethamine

## Key facts

- **NCT ID:** NCT05354258
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-16
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-09
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354258, "Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05354258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*